Dasotraline
编号: 16071017
Cas号: 675126-05-3
纯度: 98% by HPLC
Dasotraline, also known as SEP-225,289, is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that is under development by Sunovion for clinical use. The drug is no longer being developed for major depressive disorder (MDD), but is still under investigation for the treatment of attention-deficit hyperactivity disorder (ADHD) and eating disorders.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Dasotraline |
|---|---|
| Iupac 化学名称 | (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine |
| 同义词 | SEP-225,289; |
| 英文同义词 | SEP-225,289; |
| 分子式 | C16H15Cl2N |
| 分子量 | 292.203 |
| Smile | ClC=1C=C(C=CC1Cl)[C@@H]1CC[C@H](C2=CC=CC=C12)N |
| InChiKey | SRPXSILJHWNFMK-MEDUHNTESA-N |
| InChi | InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1 |
| Cas号 | 675126-05-3 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
